Search results
Harvard Bioscience President Acquires 1.6% More Stock
Simply Wall St. via Yahoo Finance· 8 months agoPotential Harvard Bioscience, Inc. (NASDAQ:HBIO) shareholders may wish to note that the President,...
Great news for Harvard Bioscience, Inc. (NASDAQ:HBIO): Insiders acquired stock in large numbers last...
Simply Wall St. via Yahoo Finance· 2 years agoGenerally, when a single insider buys stock, it is usually not a big deal. However, when several...
Is Harvard Bioscience, Inc. (NASDAQ:HBIO) Potentially Undervalued?
Simply Wall St. via Yahoo Finance· 1 year agoHarvard Bioscience, Inc. (NASDAQ:HBIO), is not the largest company out there, but it received a lot...
Harvard Bioscience, Inc. (NASDAQ:HBIO): When Will It Breakeven?
Simply Wall St. via Yahoo Finance· 1 year agoHarvard Bioscience, Inc. (NASDAQ:HBIO) is possibly approaching a major achievement in its business,...
Harvard Bioscience, Inc. (NASDAQ:HBIO) Soars 39% But It's A Story Of Risk Vs Reward
Simply Wall St. via Yahoo Finance· 12 months agoHarvard Bioscience, Inc. (NASDAQ:HBIO) shares have continued their recent momentum with a 39% gain...
Harvard Bioscience, Inc. (NASDAQ:HBIO) is largely controlled by institutional shareholders who own...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Significantly high institutional ownership implies Harvard Bioscience's stock price is...
With 60% ownership, Harvard Bioscience, Inc. (NASDAQ:HBIO) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significantly high institutional ownership implies Harvard Bioscience's stock price is...
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoHarvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2023 Earnings Call Transcript March 7, 2024 Harvard...
Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Be 36% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights The projected fair value for Harvard Bioscience is US$6.54 based on 2 Stage Free Cash...
Are Investors Undervaluing Harvard Bioscience, Inc. (NASDAQ:HBIO) By 48%?
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Harvard Bioscience fair value estimate is...